S. 3700 117th Congress
Affordable Insulin Now Act
Latest action, Feb 17, 2022: Read twice and referred to the Committee on Finance.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
36 cosponsors
Sponsored by Raphael G. Warnock (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
35 D · 0 R · 1 I
- Democrat
- Republican
- Independent
Referred to: Senate: Finance Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
4 reports
AMERICAN MEDICAL ASSOCIATION
AVENUE SOLUTIONS
4 reports
BLUE CROSS BLUE SHIELD ASSOCIATION
TIBER CREEK GROUP
4 reports
BLUE CROSS BLUE SHIELD ASSOCIATION
AVENUE SOLUTIONS
4 reports
4 reports
CIGNA CORPORATION
INVARIANT LLC
4 reports
ELEVANCE HEALTH, INC.
TIBER CREEK GROUP
4 reports
4 reports
GENENTECH USA, INC.
AVENUE SOLUTIONS
4 reports
HEALTHCARE LEADERSHIP COUNCIL
AVENUE SOLUTIONS
4 reports
INCYTE CORPORATION
AVENUE SOLUTIONS
4 reports
IOVANCE BIOTHERAPEUTICS, INC.
AVENUE SOLUTIONS
4 reports
JOHNSON & JOHNSON SERVICES, INC.
THE NICKLES GROUP, LLC
4 reports
MERCK & CO. INC.
AVENUE SOLUTIONS
4 reports
All 25 of 57 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | 4 | $13.3M | Q1 2022 | Q3 2022 | yes | |
| AMERICAN BENEFITS COUNCIL | 4 | $1.3M | Q1 2022 | Q3 2022 | yes | |
| AMERICAN MEDICAL ASSOCIATION | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| BLUE CROSS BLUE SHIELD ASSOCIATION | TIBER CREEK GROUP | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| BLUE CROSS BLUE SHIELD ASSOCIATION | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| CAMBIA HEALTH SOLUTIONS | 4 | $2.0M | Q1 2022 | Q3 2022 | yes | |
| CIGNA CORPORATION | INVARIANT LLC | 4 | $360K | Q1 2022 | Q3 2022 | yes |
| ELEVANCE HEALTH, INC. | TIBER CREEK GROUP | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| ELI LILLY AND COMPANY | 4 | $6.8M | Q1 2022 | Q3 2022 | yes | |
| GENENTECH USA, INC. | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| HEALTHCARE LEADERSHIP COUNCIL | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| INCYTE CORPORATION | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| IOVANCE BIOTHERAPEUTICS, INC. | AVENUE SOLUTIONS | 4 | $50K | Q1 2022 | Q3 2022 | yes |
| JOHNSON & JOHNSON SERVICES, INC. | THE NICKLES GROUP, LLC | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| MERCK & CO. INC. | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 4 | $3.2M | Q1 2022 | Q3 2022 | yes | |
| NATIONAL TAXPAYERS UNION | 4 | $120K | Q1 2022 | Q3 2022 | yes | |
| NOVO NORDISK INC. | 4 | $4.6M | Q1 2022 | Q3 2022 | yes | |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 4 | $8.7M | Q1 2022 | Q3 2022 | yes | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4 | $28.3M | Q1 2022 | Q3 2022 | yes | |
| SAGE THERAPEUTICS, INC. | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| SANOFI US SERVICES INC | 4 | $4.8M | Q1 2022 | Q3 2022 | yes | |
| SCAN HEALTH PLAN | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| SNP ALLIANCE INC | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| T1INTERNATIONAL USA | 4 | $0 | Q1 2022 | Q3 2022 | yes |